Matches in SemOpenAlex for { <https://semopenalex.org/work/W2017695919> ?p ?o ?g. }
Showing items 1 to 80 of
80
with 100 items per page.
- W2017695919 endingPage "502" @default.
- W2017695919 startingPage "502" @default.
- W2017695919 abstract "Systematic reviews and meta-analysis have demonstrated an improved prognosis by chemotherapy of malignant glioma patients. The effects of clinical research therefore have the aim to find more active drugs or new combination therapies. The combination of Temozolomide (TMZ) and nitrosoureas was evaluated preclinically with an evidence of therapeutic synergy. Based on these findings, we have carried out a phase I study with TMZ administered in low, prolonged doses of 75 mg/m2 per day, once a day for 21 days, escalated in cohorts of 3 patients, in combination with a fixed dose of Lomustine (CCNU) 100 mg/m2 orally on day 1. MTD was evident. The treatment was generally well tolerated. We did not observe bleeding or severe infections, as described for several combination chemotherapies with TMZ and other agents. In this study, for the first time in high grade malignant glioma, two orally administrated drugs were associated .TMZ 75 mg/m2 for 28 consecutive days and CCNU 100 mg/m2 on day 1 of every 6 weeks could be recommended as a safe treatment dosage. One of the ten patients evaluated for clinical response showed a partial response, while nine showed stability of disease, with a median duration of from 5 to 6 months." @default.
- W2017695919 created "2016-06-24" @default.
- W2017695919 creator A5012373998 @default.
- W2017695919 creator A5019522534 @default.
- W2017695919 creator A5027143754 @default.
- W2017695919 creator A5045922177 @default.
- W2017695919 creator A5059764220 @default.
- W2017695919 creator A5072545598 @default.
- W2017695919 creator A5073695437 @default.
- W2017695919 creator A5089302271 @default.
- W2017695919 date "2006-01-01" @default.
- W2017695919 modified "2023-10-18" @default.
- W2017695919 title "Phase I study of temozolomide and lomustine in the treatment of high grade malignant glioma" @default.
- W2017695919 doi "https://doi.org/10.2741/1814" @default.
- W2017695919 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16146748" @default.
- W2017695919 hasPublicationYear "2006" @default.
- W2017695919 type Work @default.
- W2017695919 sameAs 2017695919 @default.
- W2017695919 citedByCount "3" @default.
- W2017695919 countsByYear W20176959192013 @default.
- W2017695919 crossrefType "journal-article" @default.
- W2017695919 hasAuthorship W2017695919A5012373998 @default.
- W2017695919 hasAuthorship W2017695919A5019522534 @default.
- W2017695919 hasAuthorship W2017695919A5027143754 @default.
- W2017695919 hasAuthorship W2017695919A5045922177 @default.
- W2017695919 hasAuthorship W2017695919A5059764220 @default.
- W2017695919 hasAuthorship W2017695919A5072545598 @default.
- W2017695919 hasAuthorship W2017695919A5073695437 @default.
- W2017695919 hasAuthorship W2017695919A5089302271 @default.
- W2017695919 hasBestOaLocation W20176959191 @default.
- W2017695919 hasConcept C126322002 @default.
- W2017695919 hasConcept C143998085 @default.
- W2017695919 hasConcept C2776694085 @default.
- W2017695919 hasConcept C2776755627 @default.
- W2017695919 hasConcept C2777389519 @default.
- W2017695919 hasConcept C2778227246 @default.
- W2017695919 hasConcept C2779429289 @default.
- W2017695919 hasConcept C2779434656 @default.
- W2017695919 hasConcept C2780964509 @default.
- W2017695919 hasConcept C31760486 @default.
- W2017695919 hasConcept C502942594 @default.
- W2017695919 hasConcept C71924100 @default.
- W2017695919 hasConcept C90924648 @default.
- W2017695919 hasConcept C98274493 @default.
- W2017695919 hasConceptScore W2017695919C126322002 @default.
- W2017695919 hasConceptScore W2017695919C143998085 @default.
- W2017695919 hasConceptScore W2017695919C2776694085 @default.
- W2017695919 hasConceptScore W2017695919C2776755627 @default.
- W2017695919 hasConceptScore W2017695919C2777389519 @default.
- W2017695919 hasConceptScore W2017695919C2778227246 @default.
- W2017695919 hasConceptScore W2017695919C2779429289 @default.
- W2017695919 hasConceptScore W2017695919C2779434656 @default.
- W2017695919 hasConceptScore W2017695919C2780964509 @default.
- W2017695919 hasConceptScore W2017695919C31760486 @default.
- W2017695919 hasConceptScore W2017695919C502942594 @default.
- W2017695919 hasConceptScore W2017695919C71924100 @default.
- W2017695919 hasConceptScore W2017695919C90924648 @default.
- W2017695919 hasConceptScore W2017695919C98274493 @default.
- W2017695919 hasIssue "1" @default.
- W2017695919 hasLocation W20176959191 @default.
- W2017695919 hasLocation W20176959192 @default.
- W2017695919 hasOpenAccess W2017695919 @default.
- W2017695919 hasPrimaryLocation W20176959191 @default.
- W2017695919 hasRelatedWork W2017695919 @default.
- W2017695919 hasRelatedWork W2031376430 @default.
- W2017695919 hasRelatedWork W2032862134 @default.
- W2017695919 hasRelatedWork W2096460953 @default.
- W2017695919 hasRelatedWork W2121585125 @default.
- W2017695919 hasRelatedWork W2148037622 @default.
- W2017695919 hasRelatedWork W2283634263 @default.
- W2017695919 hasRelatedWork W2374912696 @default.
- W2017695919 hasRelatedWork W2418968497 @default.
- W2017695919 hasRelatedWork W2462822954 @default.
- W2017695919 hasVolume "11" @default.
- W2017695919 isParatext "false" @default.
- W2017695919 isRetracted "false" @default.
- W2017695919 magId "2017695919" @default.
- W2017695919 workType "article" @default.